Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Europe Enteral Medical Nutrition Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]
- Report Code : BMIRE00027518
- Pages : 218
The enteral medical nutrition market in Europe is expected to grow from US$ 4,042.08 million in 2022 to US$ 2,857.47 million by 2028. It is estimated to grow at a CAGR of 5.9% from 2022 to 2028.
Rise in Prevalence of Gastrointestinal Diseases
Crohn’s disease, gastrointestinal disease due to trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are a few gastrointestinal diseases. According to Medscape, in developed countries, the most common cause of small-bowel obstruction (SBO) is intra-abdominal adhesions, accounting for ~65 to 75% of cases, followed by hernias. In contrast, in developing countries, SBO is primarily caused by hernias (30–40%), adhesions (about 30%), and tuberculosis (about 10%).
Patients with gastrointestinal disease are at an increased risk of nutritional deterioration due to fasting for the diagnostic tests, therapeutic dietary restriction, and loss of appetite due to anorexia or altered nutritional requirement which is caused due to the disease itself. Enteral medical nutrition is preferred for the gastrointestinal disease patients as these patients cannot consume food orally and therefore enteral route is preferred to provide the required nutrients. Therefore, the growing prevalence of gastrointestinal diseases, especially in developing countries, drives the growth of the enteral medical nutrition market.
Market Overview
The Europe enteral medical nutrition market has been segmented into the US, Canada, and Mexico. The US held the largest share of the Europe enteral medical nutrition market in 2021. The increasing prevalence of chronic diseases followed by rising research and development activities by various major firms, increasing expenditure on patient care, and increasing preference for enteral nutrition ultimately drive the overall enteral medical nutrition market during the forecast period. Further, The US enteral medical nutrition market holds the largest share in the Europe region. The rising prevalence of chronic diseases is likely to favor market growth. Chronic diseases such as cancer, heart disease, and diabetes are the leading causes of disability and death in the US. As per the National Center for Chronic Disease Prevention and Health Promotion, six in ten Americans have at least one chronic disease, such as heart disease, stroke, cancer, diabetes, and others.
Increasing expenditure on chronic health conditions is likely to favor market growth. In 2016, the total costs in the US. for direct treatment for chronic diseases was US$1.1 trillion, equivalent to around 6% of the nation’s GDP. Further, in 2020, the total expenditure of chronic diseases in the US reached US$3.7 trillion, which is around 19.6% of the country’s GDP.
The US government is taking many initiatives to boost the enteral nutrition market. For instance, the Feeding Tube Awareness Foundation is creating awareness about feeding tube adoption. The foundation has celebrated the annual Feeding Tube Awareness Week from February 4 to February 8, 2019. More than 500,000 children and adults in the US depend on enteral feeding for nutrition, and the number is expected to increase in the forecast period.
Europe Enteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)
Europe Enteral Medical Nutrition Market Segmentation
The Europe enteral medical nutrition market is segmented into indication, nutrition type, form, product, distribution channel, age group and country.
Based on indication, the Europe enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The respiratory disorders segment held the largest share in 2022. Based on nutrition type, the Europe enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held the largest share of the market in 2022. Based on form, the Europe enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held the largest share of the market in 2022. Based on product, the Europe enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held the largest share of the market in 2022. Based on distribution channel, the Europe Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held the largest share of the market in 2022. Based on Age Group, the Europe enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). The adult segment held the largest share of the market in 2022. Based on country, the market is segmented into France, Germany, Italy, Spain, UK, and the Rest of Europe. Germany dominated the market in 2022. Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS are the leading companies operating in the enteral medical nutrition market in the region.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Enteral Medical Nutrition Market – By Indication
1.3.2 Europe Enteral Medical Nutrition Market – By Nutrition Type
1.3.3 Europe Enteral Medical Nutrition Market – By Form
1.3.4 Europe Enteral Medical Nutrition Market – By Product
1.3.5 Europe Enteral Medical Nutrition Market – By Distribution Channel
1.3.6 Europe Enteral Medical Nutrition Market – By Age Group
1.3.7 Europe Enteral Medical Nutrition Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Enteral Medical Nutrition Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Enteral Medical Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Cachexia
5.1.2 Rise in Prevalence of Gastrointestinal Diseases
5.2 Market Restraints
5.2.1 Complications of Enteral Nutrition
5.3 Market Opportunities
5.3.1 Use of Next Generation Technology for Proper Enteral Nutrition Feeding
5.4 Future Trends
5.4.1 Developments Related to Enteral Medical Nutrition Products
5.5 Impact Analysis
6. Enteral Medical Nutrition Market – Europe Analysis
6.1 Europe Enteral Medical Nutrition Market Revenue Forecast and Analysis
7. Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Indication
7.1 Overview
7.2 Europe Enteral Medical Nutrition Market, by Indication, 2022 & 2028 (%)
7.3 Respiratory Disorders
7.3.1 Overview
7.3.2 Respiratory Disorders Market Revenue and Forecast to 2028 (US$ Million)
7.3.3 Chronic Obstructive Pulmonary Disease
7.3.3.1 Overview
7.3.3.2 Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2028 (US$ Million)
7.3.4 Respiratory Failure
7.3.4.1 Overview
7.3.4.2 Respiratory Failure Market Revenue and Forecast to 2028 (US$ Million)
7.3.5 Cystic Fibrosis
7.3.5.1 Overview
7.3.5.2 Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer
7.4.1 Overview
7.4.2 Cancer Market Revenue and Forecast to 2028 (US$ Million)
7.4.3 Cancer Cachexia
7.4.3.1 Overview
7.4.3.2 Cancer Cachexia Market Revenue and Forecast to 2028 (US$ Million)
7.4.4 Cachexia with COPD
7.4.4.1 Overview
7.4.4.2 Cachexia with COPD Market Revenue and Forecast to 2028 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.5 Post COVID-19
7.5.1 Overview
7.5.2 Post COVID-19 Market Revenue and Forecast to 2028 (US$ Million)
7.6 Gastrointestinal Disorders
7.6.1 Overview
7.6.2 Gastrointestinal Disorders Market Revenue and Forecast to 2028 (US$ Million)
7.6.3 Bowel Obstruction
7.6.3.1 Overview
7.6.3.2 Bowel Obstruction Market Revenue and Forecast to 2028 (US$ Million)
7.6.4 Crohn’s Disease
7.6.4.1 Overview
7.6.4.2 Crohn’s Disease Market Revenue and Forecast to 2028 (US$ Million)
7.6.5 Short Bowel Syndrome
7.6.5.1 Overview
7.6.5.2 Short Bowel Syndrome Market Revenue and Forecast to 2028 (US$ Million)
7.6.6 Others
7.6.6.1 Overview
7.6.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.7 Liver Failure
7.7.1 Overview
7.7.2 Liver Failure Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Other Market Revenue and Forecast to 2028 (US$ Million)
8. Europe Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Nutrition Type
8.1 Overview
8.2 Europe Enteral Medical Nutrition Market, by Nutrition Type, 2022 & 2028 (%)
8.3 Supplemental
8.3.1 Overview
8.3.2 Supplemental Market Revenue and Forecast to 2028 (US$ Million)
8.4 Sole-Source
8.4.1 Overview
8.4.2 Sole-Source Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Form
9.1 Overview
9.2 Europe Enteral Medical Nutrition Market, by Form, 2022 & 2028 (%)
9.3 Powder
9.3.1 Overview
9.3.2 Powder Market Revenue and Forecast to 2028 (US$ Million)
9.4 Liquid
9.4.1 Overview
9.4.2 Liquid Market Revenue and Forecast to 2028 (US$ Million)
9.5 Semi-Solid
9.5.1 Overview
9.5.2 Semi-Solid Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Product
10.1 Overview
10.2 Europe Enteral Medical Nutrition Market, by Product, 2022 & 2028 (%)
10.3 Standard Protein Diet
10.3.1 Overview
10.3.2 Standard Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
10.4 High Protein Diet
10.4.1 Overview
10.4.2 High Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
10.5 Fruit Juice Based Oral Nutritional Supplement
10.5.1 Overview
10.5.2 Fruit Juice Based Oral Nutritional Supplement Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Other Market Revenue and Forecast to 2028 (US$ Million)
11. Europe Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Distribution Channel
11.1 Overview
11.2 Europe Enteral Medical Nutrition Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
11.3.1 Overview
11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
11.4.1 Overview
11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. Europe Enteral Medical Nutrition Market Analysis and Forecast to 2028 – Age Group
12.1 Overview
12.2 Europe Enteral Medical Nutrition Market, by Age Group, 2022 & 2028 (%)
12.3 Child (Till 18 Years)
12.3.1 Overview
12.3.2 Child Market Revenue and Forecast to 2028 (US$ Million)
12.4 Adult (Above 18+ Years)
12.4.1 Overview
12.4.2 Adult Market Revenue and Forecast to 2028 (US$ Million)
13. Europe Enteral Medical Nutrition Market Revenue and Forecasts to 2028 – Country Analysis
13.1 Overview
13.1.1 Europe: Enteral Medical Nutrition Market, by Country, 2021 & 2028 (%)
13.1.1.1 Germany: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.1 Overview
13.1.1.1.2 Germany: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.3 Germany: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.1.3.1 Germany: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.1.3.2 Germany: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.1.3.3 Germany: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.1.4 Germany: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.1.5 Germany: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.1.6 Germany: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.1.7 Germany: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.1.8 Germany: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.2 UK: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.1 Overview
13.1.1.2.2 UK: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.3 UK: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.2.3.1 UK: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.2.3.2 UK: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.2.3.3 UK: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.2.4 UK: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.2.5 UK: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.2.6 UK: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.2.7 UK: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.2.8 UK: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.3 France: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.1 Overview
13.1.1.3.2 France: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.3 France: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.3.3.1 France: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.3.3.2 France: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.3.3.3 France: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.3.4 France: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.3.5 France: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.3.6 France: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.3.7 France: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.3.8 France: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.4 Italy: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.4.1 Overview
13.1.1.4.2 Italy: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.4.3 Italy: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.4.3.1 Italy: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.4.3.2 Italy: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.4.3.3 Italy: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.4.4 Italy: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.4.5 Italy: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.4.6 Italy: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.4.7 Italy: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.4.8 Italy: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.5 Spain: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.5.1 Overview
13.1.1.5.2 Spain: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.5.3 Spain: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.5.3.1 Spain: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.5.3.2 Spain: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.5.3.3 Spain: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.5.4 Spain: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.5.5 Spain: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.5.6 Spain: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.5.7 Spain: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.5.8 Spain: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
13.1.1.6 Rest of Europe: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.6.1 Overview
13.1.1.6.2 Rest of Europe: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.6.3 Rest of Europe: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
13.1.1.6.3.1 Rest of Europe: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
13.1.1.6.3.2 Rest of Europe: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
13.1.1.6.3.3 Rest of Europe: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
13.1.1.6.4 Rest of Europe: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
13.1.1.6.5 Rest of Europe: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
13.1.1.6.6 Rest of Europe: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
13.1.1.6.7 Rest of Europe: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
13.1.1.6.8 Rest of Europe: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
14. Enteral Medical Nutrition Market– Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 Abbott Laboratories
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Nutricia
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Fresenius Kabi AG
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 B. Braun Melsungen AG
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Nestlé S.A.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Meiji Holdings Co., Ltd.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Smartfish AS
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 DSM Nutritional Products AG
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Hormel Foods Corporation
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Global Health Products, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms in Enteral Medical Nutrition Market
LIST OF TABLES
Table 1. Germany Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 5. Germany Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Germany Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 7. Germany Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 8. Germany Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 9. Germany Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 10. UK Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. UK Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 12. UK Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 13. UK Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 14. UK Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 15. UK Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 16. UK Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 17. UK Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 18. UK Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 19. France Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 20. France Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 21. France Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 22. France Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 23. France Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 24. France Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 25. France Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 26. France Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 27. France Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 28. Italy Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 29. Italy Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 30. Italy Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 31. Italy Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 32. Italy Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 33. Italy Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 34. Italy Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 35. Italy Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 36. Italy Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 37. Spain Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 38. Spain Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 39. Spain Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 40. Spain Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 41. Spain Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 42. Spain Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 43. Spain Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 44. Spain Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 45. Spain Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 46. Rest of Europe Enteral Medical Nutrition Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 47. Rest of Europe Enteral Medical Nutrition Market, by Respiratory Disorders – Revenue and Forecast to 2028 (USD Million)
Table 48. Rest of Europe Enteral Medical Nutrition Market, by Cancer – Revenue and Forecast to 2028 (USD Million)
Table 49. Rest of Europe Enteral Medical Nutrition Market, by Gastrointestinal Disorders – Revenue and Forecast to 2028 (USD Million)
Table 50. Rest of Europe Enteral Medical Nutrition Market, by Nutrition Type – Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe Enteral Medical Nutrition Market, by Form – Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Europe Enteral Medical Nutrition Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe Enteral Medical Nutrition Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe Enteral Medical Nutrition Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 55. Organic Developments Done By Companies
Table 56. Inorganic Developments Done By Companies
Table 57. Glossary of Terms in Europe Enteral Medical Nutrition Market
LIST OF FIGURES
Figure 1. Europe Enteral Medical Nutrition Market Segmentation
Figure 2. Europe Enteral Medical Nutrition Market, By Country
Figure 3. Europe Enteral Medical Nutrition Market Overview
Figure 4. Respiratory Disorders Segment Held Largest Share of Indication Segment in Europe Enteral Medical Nutrition Market
Figure 5. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Enteral Medical Nutrition Market– Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Enteral Medical Nutrition Market, by Indication, 2022 & 2028 (%)
Figure 10. Europe Respiratory Disorders Market Revenue and Forecast to 2028 (US$ Million)
Figure 11. Europe Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Respiratory Failure Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Cancer Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Cancer Cachexia Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Cachexia with COPD Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Post COVID-19 Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Gastrointestinal Disorders Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Bowel Obstruction Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Crohn’s Disease Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Short Bowel Syndrome Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Liver Failure Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe Enteral Medical Nutrition Market, by Nutrition Type, 2022 & 2028 (%)
Figure 28. Europe Supplemental Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Sole-Source Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Europe Enteral Medical Nutrition Market, by Form, 2022 & 2028 (%)
Figure 31. Europe Powder Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe Liquid Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Europe Semi-Solid Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Europe Enteral Medical Nutrition Market, by Product, 2022 & 2028 (%)
Figure 35. Europe Standard Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. Europe High Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe Fruit Juice Based Oral Nutritional Supplement Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Europe Other Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe Enteral Medical Nutrition Market, by Distribution Channel, 2022 & 2028 (%)
Figure 40. Europe Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. Europe Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 43. Europe Enteral Medical Nutrition Market, by Age Group, 2022 & 2028 (%)
Figure 44. Europe Child Market Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe Adult Market Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Enteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 47. Europe: Enteral Medical Nutrition Market, by Country, 2021 & 2028 (%)
Figure 48. Germany: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. UK: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. France: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Italy: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Spain: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Rest of Europe: Enteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Growth Strategies Done by the Companies in the Market, (%)
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe enteral medical nutrition market
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe enteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the enteral medical nutrition market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
The List of Companies – Europe Enteral Medical Nutrition Market
● Abbott Laboratories
● B. Braun Melsungen AG
● DSM Nutritional Products AG
● Fresenius Kabi AG
● Global Health Products, Inc.
● Hormel Foods Corporation
● Meiji Holdings Co., Ltd.
● Nestlé S.A.
● Nutricia
● Smartfish AS
At 5.9% CAGR, the Europe Enteral Medical Nutrition Market is speculated to be worth US$ 4,042.08 Million by 2028, says The Insight Partners
According to The Insight Partners’ research, the Europe enteral medical nutrition market was valued at US$ 2,857.47 million in 2022 and is expected to reach US$ 4,042.08 million by 2028, registering an annual growth rate of 5.9% from 2022 to 2028. Increase in prevalence of cachexia and rise in prevalence of gastrointestinal diseases are the critical factors attributed to the market expansion.
Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. It is a serious clinical consequence of almost all chronic diseases when reaching advanced stages. According to NCBI (National Center for Biotechnology Information), in 2016, cachexia prevalence ranged from 5 to 15% in end-stage chronic heart failure. It is frequently occurring in patients suffering from chronic kidney disease, chronic obstructive pulmonary disease (COPD), neurological disease, and rheumatoid arthritis. Mortality rates of cachexia patients range from 15 to 25% per year in patients with severe COPD and from 20 to 40% per year in patients with chronic heart failure or chronic kidney disease.
Cancer cachexia negatively affects the quality of life of cancer patients and reduces the effectiveness of anticancer chemotherapy and increases its toxicity, leading to growth in cancer-related mortality and medical resources expenditure. In cachexia the nutrient in the body decreases therefore it is necessary to provide external nutrients to continue the treatment for cancer and COPD. Doctors prefer enteral route to provide these required nutrients to the patient. Therefore, growing prevalence of cachexia due to the rising incidence of various chronic diseases fuels the growth of the enteral medical nutrition market.
On the contrary, complications of enteral nutrition hurdle the growth of Europe enteral medical nutrition market.
Based on indication, the Europe enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. Respiratory disorders held 40.6% market share in 2022, amassing US$ 1,159.85 million. It is projected to garner US$ 1,588.58 million by 2028 to expand at 5.4% CAGR during 2022–2028. Based on nutrition type, the Europe enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held 78.5% market share in 2022, amassing US$ 2,243.79 million. It is projected to garner US$ 3,132.54 million by 2028 to expand at 5.7% CAGR during 2022–2028. Based on form, the Europe enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held 48.7% market share in 2022, amassing US$ 1,519.78 million. It is projected to garner US$ 2,185.88 million by 2028 to expand at 6.2% CAGR during 2022–2028. Based on product, the Europe enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held 52.0% market share in 2022, amassing US$ 1,486.02 million. It is projected to garner US$ 2,067.49 million by 2028 to expand at 5.7% CAGR during 2022–2028. Based on distribution channel, the Europe Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held 59.5% market share in 2022, amassing US$ 1,699.27 million. It is projected to garner US$ 2,375.96 million by 2028 to expand at 5.7% CAGR during 2022–2028. Based on Age Group, the Europe enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). With 90.2% share of the domain, the adults segment dominated the market in 2022. It accrued US$ 2,576.67 million in 2022 and is estimated to generate US$ 3,615.51 million by 2028 to grow at a CAGR of 5.8% over the forecast period. Our regional analysis states that Germany captured 29.5% market share in 2022. It was assessed at US$ 841.53 million in 2022 and is likely to hit US$ 1,163.72 million by 2028, exhibiting a CAGR of 5.6% during the forecast period.
Key players dominating the Europe enteral medical nutrition market are Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS among others.
Related Reports
- $3,000.00 – $5,000.00
